We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Portable Blood Analysis System Provides Rapid Accurate Results

By LabMedica International staff writers
Posted on 21 Jan 2009
A portable blood analysis system is used in any human patient-care setting to provide clinicians with rapid blood constituent measurements.

The new system consists of a compact 5.1 kg portable analyzer and a series of single-use plastic discs. More...
These reagent discs contain all the chemicals required to perform a panel of up to 14 tests on human patients, as well as 13 tests on veterinary patients.

The analyzer requires minimal training of lab personnel in order for them to be able to operate and perform multiple routine tests on whole blood, serum, or plasma samples. The new system offers the precision and accuracy equivalent to a clinical laboratory analyzer. The analyzer is a product of Abaxis (Union City, CA, USA), a medical products company that manufactures point-of-care blood analysis systems.

Abaxis originally developed Piccolo technology for the National Aeronautics and Space Organization (NASA). It is routinely used by the U.S. military, physician offices, hospitals, urgent care clinics, and oncology clinics. The next generation compact Piccolo Xpress analyzer provides multi chemistry panels in virtually any treatment setting with the precision and accuracy of larger laboratory analyzers.

Abaxis veterinary business also provides a line of hematology instruments for point-of-care complete blood counts (CBC) to the veterinarian and research market

Related Links:

Abaxis




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.